Telomerase activation also creates an unresolved safety concern
Its status in research is that of a synthetic cytoprotective agent a compound studied for its ability to protect and restore tissue integrity across multiple organ systems in animal models [8]
Discover common reasons behind these symptoms
PLoS ONE 11 , e0151692 (2016)
The Panel used the IC/BPS definition agreed upon by the Society for Urodynamics and Female Urology (SUFU): "An unpleasant sensation (pain, pressure, discomfort) perceived to be related to the urinary bladder, associated with lower urinary tract symptoms of more than six weeks duration, in the absence of infection or other identifiable causes. 2 This definition was selected because it allows treatment to begin after a relatively short symptomatic period, preventing treatment withholding that could occur with definitions that require longer symptom durations (i.e., six months)
La solution peut tre bue dilue dans un verre d'eau Notices d'utilisation Consulter la notice en ligne En cas d'effets indsirables, prenez contact immdiatemment avec votre mdecin traitant